Drawing on its recognised expertise in brokerage in convertible bonds and in European options, Exane Derivatives, a subsidiary of Exane Group, has developed a complete range of products, based on skills from conception to execution: brokerage and market making on options and futures, brokerage in convertible bonds and design of cross-asset investment solutions. Ranked at no.1 in equity options market making (Eurex 2017), it is today one of Europe's main liquidity providers. Its structured solutions platform also issues innovative products that cover institutional and private clients’ investment objectives in Europe and Latin America. Exane Derivatives leverages a dedicated and wholly in-house equity and credit Research to identify the best market opportunities and propose investment themes. About Exane Group Founded in 1990, the Exane Group is one of the main independent investment companies in Europe, specialising in 3 business lines, with Research as a core focus: cash equities (under the brand name Exane BNP Paribas), derivatives (Exane Derivatives) and asset management (Exane asset management and Ellipsis AM, based respectively on the equity and fixed-income universes). Since 2004, cash equities business has been a core feature of Exane's partnership with BNP Paribas, BNP Paribas entrusting this activity exclusively to Exane for European equities. The 930 employees of the Group are now spread across 10 sites worldwide, mainly in Paris and London.